#
Combipatch
  • Drugs A to Z

Combipatch (Transdermal)

Generic name:estradiol and norethindrone (transdermal route) [ es-tra-DYE-ol, nor-ETH-in-drone-AS-e-tate ]
Drug class:Sex hormone combinations

Medically reviewed by Drugs.com. Last updated on Apr 16, 2022.

Transdermal route(Patch, Extended Release)

Estrogens with or without progestins should not be used for the prevention of cardiovascular disease or dementia. An increased risk of DVT, pulmonary embolism, stroke, myocardial infarction, and invasive breast cancer have been reported. An increased risk of probable dementia in postmenopausal women 65 years of age or older has also been reported. There is an increased risk of endometrial cancer in women with a uterus who use unopposed estrogens. Estrogens with or without progestins should be prescribed at the lowest effective doses and for the shortest duration consistent with treatment goals and risks for the individual woman .

Commonly used brand name(s)

In the U.S.

  • Combipatch

In Canada

  • Estalis
  • Estalis-Sequi

Available Dosage Forms:

  • Patch, Extended Release

Therapeutic Class: Estrogen/Progestin Combination

Pharmacologic Class: Estrogen

Uses for Combipatch

Estradiol and norethindrone skin patch is used to treat moderate to severe hot flashes and other symptoms of menopause. It is also used to treat changes in and around the vagina (such as vaginal dryness, itching, and burning) caused by low estrogen levels or menopause. This medicine is also used to treat certain conditions in women before menopause if their ovaries do not make enough estrogens naturally.

This medicine is a combination of two hormones: an estrogen hormone (estradiol) and a progestin hormone (norethindrone). These hormones are absorbed through your skin into your body. It works by preventing symptoms, such as feelings of warmth in the face, neck, and chest, or sudden strong feelings of heat and sweating (hot flashes) in women during menopause.

This medicine is available only with your doctor's prescription.

Before using Combipatch

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Use of CombiPatch® is not indicated in children.

Geriatric

Although appropriate studies on the relationship of age to the effects of CombiPatch® have not been performed in the geriatric population, no geriatric-specific problems have been documented to date. However, elderly patients are more likely to have breast cancer, strokes, or dementia, which may require caution in patients receiving this medicine.

Breastfeeding

There are no adequate studies in women for determining infant risk when ..